![Sanjay Suri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sanjay Suri
Vorstandsvorsitzender bei
MOREPEN LABORATORIES LIMITED
Vermögen: 2 Mio $ am 30.06.2026
Profil
Sanjay Suri currently works at Morepen Laboratories Ltd., as Co-Managing Director from 2026, Mid-Med Financial Services & Investments Pvt Ltd., as Director, Solace Investments & Financial Services Pvt Ltd., as Director, Solitary Investment & Financial Services Pvt Ltd., as Director, Shivalik Pesticides & Chemicals Pvt Ltd., as Director, Dr. Morepen Ltd., as Managing Director & Director, Total Care Ltd., as Director, Liquid Holdings Pvt Ltd., as Director, Silver Resort Hotel India Pvt Ltd., as Director, Blueheaven Marketing Pvt Ltd., as Director, Happier Life Pvt Ltd., as Director, Zios Medical Centre Pvt Ltd., as Director, Morepen Bio Ltd., as Director, and Morepen Rx Ltd., as Director.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2025 | 3 417 240 ( 0,62 % ) | 2 Mio $ | 30.06.2026 |
Aktive Positionen von Sanjay Suri
| Unternehmen | Position | Beginn |
|---|---|---|
| MOREPEN LABORATORIES LIMITED | Vorstandsvorsitzender | 01.07.2026 |
Total Care Ltd. /India/ | Direktor/Vorstandsmitglied | 30.05.2011 |
Dr. Morepen Ltd.
 Dr. Morepen Ltd. Part of Morepen Laboratories Ltd., Dr. Morepen Ltd. is a pharmaceutical company specializing in active pharmaceutical ingredients (APIs), finished formulations, diagnostics, and over-the-counter healthcare products. The company operates manufacturing facilities, including a large complex in Baddi with 10 specialized plants, producing generic bulk drugs such as montelukast, loratadine, atorvastatin, and rosuvastatin. The company maintains over 100 product combinations, 54 patents, and serves regulated and non-regulated markets in more than 75 countries. It offers finished formulations and nutraceuticals under brands such as Dr. Morepen and Gubb World, and has a presence in home health diagnostics with over 14 million glucometers installed worldwide. The company is based in New Delhi, India. The company was founded in 2001. Dr. Morepen focuses on research and development for new molecule development and non-infringing technologies, supporting a broad product pipeline across therapeutic areas like anti-diabetic, anti-psychotic, and cardiology. The CEO is Sanjay Suri. | Vorstandsvorsitzender | 30.05.2011 |
Silver Resort Hotel India Pvt Ltd.
 Silver Resort Hotel India Pvt Ltd. Hotels/Resorts/Cruise linesConsumer Services Owns and operates as hotels and resorts | Direktor/Vorstandsmitglied | - |
Shivalik Pesticides & Chemicals Pvt Ltd. | Direktor/Vorstandsmitglied | - |
Blueheaven Marketing Pvt Ltd. | Direktor/Vorstandsmitglied | - |
Mid-Med Financial Services & Investments Pvt Ltd. | Direktor/Vorstandsmitglied | - |
Solitary Investment & Financial Services Pvt Ltd. | Direktor/Vorstandsmitglied | - |
Solace Investments & Financial Services Pvt Ltd. | Direktor/Vorstandsmitglied | - |
| ░░░░░░ ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Morepen Laboratories Ltd.
 Morepen Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures generic drugs and pharmaceutical formulations | Health Technology |
Mid-Med Financial Services & Investments Pvt Ltd. | |
Solace Investments & Financial Services Pvt Ltd. | |
Solitary Investment & Financial Services Pvt Ltd. | |
Shivalik Pesticides & Chemicals Pvt Ltd. | |
Dr. Morepen Ltd.
Dr. Morepen Ltd. Part of Morepen Laboratories Ltd., Dr. Morepen Ltd. is a pharmaceutical company specializing in active pharmaceutical ingredients (APIs), finished formulations, diagnostics, and over-the-counter healthcare products. The company operates manufacturing facilities, including a large complex in Baddi with 10 specialized plants, producing generic bulk drugs such as montelukast, loratadine, atorvastatin, and rosuvastatin. The company maintains over 100 product combinations, 54 patents, and serves regulated and non-regulated markets in more than 75 countries. It offers finished formulations and nutraceuticals under brands such as Dr. Morepen and Gubb World, and has a presence in home health diagnostics with over 14 million glucometers installed worldwide. The company is based in New Delhi, India. The company was founded in 2001. Dr. Morepen focuses on research and development for new molecule development and non-infringing technologies, supporting a broad product pipeline across therapeutic areas like anti-diabetic, anti-psychotic, and cardiology. The CEO is Sanjay Suri. | |
Total Care Ltd. /India/ | |
Liquid Holdings Pvt Ltd.
 Liquid Holdings Pvt Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Silver Resort Hotel India Pvt Ltd.
Silver Resort Hotel India Pvt Ltd. Hotels/Resorts/Cruise linesConsumer Services Owns and operates as hotels and resorts | Consumer Services |
Blueheaven Marketing Pvt Ltd. | |
Happier Life Pvt Ltd. | |
Zios Medical Centre Pvt Ltd. |
Wählen Sie MarketScreener 
